Stress signaling and the shaping of the mammary tissue in development and cancer

Oncogene

Volumn 33, Issue 48, 2014, Pages 5483-5490

  Avivar Valderas, A ^a   Wen, H C ^a   Aguirre Ghiso, J A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

anoikis; autophagy; breast cancer; ECM; mammary gland; stress

Indexed keywords

ANIMAL; BREAST TUMOR; FEMALE; HUMAN; MAMMARY GLAND; MORPHOGENESIS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MORPHOGENESIS; SIGNAL TRANSDUCTION;

EID: 84891750523     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.554     Document Type: Review

References (112)

1. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21: 1621-1635.
2. Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D et al. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol 2000; 157: 2151-2159.
3. Mandriota SJ, Buser R, Lesne L, Stouder C, Favaudon V, Maechler P et al. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells. J Biol Chem 2010; 285: 13092-13106.
4. Sivaraman L, Conneely OM, Medina D, O'Malley BW. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 2001; 98: 12379-12384.
5. Sequeira SJ, Ranganathan AC, Adam AP, Iglesias BV, Farias EF, Aguirre-Ghiso JA. Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation. PLoS One 2007; 2: E615.
6. Wen HC, Avivar-Valderas A, Sosa MS, Girnius N, Farias EF, Davis RJ et al. p38alpha signaling induces anoikis and lumen formation during mammary morphogenesis. Sci Signal 2011; 4: Ra34.
7. Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C, Romero M, Cavener DR, Thompson CB et al. PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc Natl Acad Sci USA 2008; 105: 16314-16319.
8. Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, Diehl JA, Nagi C, Debnath J et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol 2011; 31: 3616-3629.
9. Hall HG, Farson DA, Bissell MJ. Lumen formation by epithelial cell lines in response to collagen overlay: A morphogenetic model in culture. Proc Natl Acad Sci USA 1982; 79: 4672-4676.
10. Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 2010; 3: A003228.
11. Bateman JF, Boot-Handford RP, Lamande SR. Genetic diseases of connective tissues: Cellular and extracellular effects of ECM mutations. Nat Rev Genet 2009; 10: 173-183.
12. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436: 123-127.
13. Ossowski L, Biegel D, Reich E. Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 1979; 16: 929-940.
14. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008; 6: 11.
15. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011; 17: 1109-1115.
16. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S et al. Apoptosis in the terminal endbud of the murine mammary gland: A mechanism of ductal morphogenesis. Development 1996; 122: 4013-4022.
17. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002; 111: 29-40.
18. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5: 733-740.
19. Martin-Belmonte F, Yu W, Rodriguez-Fraticelli AE, Ewald AJ, Werb Z, Alonso MA et al. Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol 2008; 18: 507-513.
20. Jechlinger M, Podsypanina K, Varmus H. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. Genes Dev 2009; 23: 1677-1688.
21. Lockshin RA, Zakeri Z. Cell death in health and disease. J Cell Mol Med 2007; 11: 1214-1224.
22. Kultz D. Evolution of the cellular stress proteome: From monophyletic origin to ubiquitous function. J Exp Biol 2003; 206: 3119-3124.
23. Smith ML, Fornace Jr AJ. Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mutat Res 1996; 340: 109-124.
24. Bartek J, Lukas J. Mammalian G1-and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001; 13: 738-747.
25. Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, Yaffe MB. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005; 17: 37-48.
26. Seong YS, Kamijo K, Lee JS, Fernandez E, Kuriyama R, Miki T et al. A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J Biol Chem 2002; 277: 32282-32293.
27. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280: 599-602.
28. del Barco Barrantes I, Nebreda AR. Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans 2012; 40: 79-84.
29. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74: 739-789.
30. Ellis RJ, Hartl FU. Principles of protein folding in the cellular environment. Curr Opin Struct Biol 1999; 9: 102-110.
31. Feder ME, Hofmann GE. Heat-shock proteins, molecular chaperones, and the stress response: Evolutionary and ecological physiology. Annu Rev Physiol 1999; 61: 243-282.
32. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994; 78: 1027-1037.
33. Rodier F, Campisi J, Bhaumik D. Two faces of p53: Aging and tumor suppression. Nucleic Acids Res 2007; 35: 7475-7484.
34. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 4675-4680.
35. Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 2009; 28: 1505-1517.
36. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007; 11: 191-205.
37. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 2000; 14: 574-584.
38. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999; 22: 667-676.
39. Das M, Garlick DS, Greiner DL, Davis RJ. The role of JNK in the development of hepatocellular carcinoma. Genes Dev 2011; 25: 634-645.
40. Waetzig V, Herdegen T. A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death. J Biol Chem 2003; 278: 567-572.
41. Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF et al. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61-70.
42. Li X, Qiu J, Wang J, Zhong Y, Zhu J, Chen Y. Corticosterone-induced rapid phosphorylation of p38 and JNK mitogen-activated protein kinases in PC12 cells. FEBS Lett 2001; 492: 210-214.
43. Miller AL, Garza AS, Johnson BH, Thompson EB. Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int 2007; 7: 3.
44. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoidinduced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 2005; 19: 1569-1583.
45. Qi AQ, Qiu J, Xiao L, Chen YZ. Rapid activation of JNK and p38 by glucocorticoids in primary cultured hippocampal cells. J Neurosci Res 2005; 80: 510-517.
46. Li S, Rosen JM. Glucocorticoid regulation of rat whey acidic protein gene expression involves hormone-induced alterations of chromatin structure in the distal promoter region. Mol Endocrinol 1994; 8: 1328-1335.
47. Rosen JM, Zahnow C, Kazansky A, Raught B. Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem Soc Symp 1998; 63: 101-113.
48. Zettl KS, Sjaastad MD, Riskin PM, Parry G, Machen TE, Firestone GL. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc Natl Acad Sci USA 1992; 89: 9069-9073.
49. Murtagh J, McArdle E, Gilligan E, Thornton L, Furlong F, Martin F. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J Cell Biol 2004; 166: 133-143.
50. Cellurale C, Girnius N, Jiang F, Cavanagh-Kyros J, Lu S, Garlick DS et al. Role of JNK in mammary gland development and breast cancer. Cancer Res 2011; 72: 472-481.
51. Cellurale C, Weston CR, Reilly J, Garlick DS, Jerry DJ, Sluss HK et al. Role of JNK in a Trp53-dependent mouse model of breast cancer. PLoS One 2010; 5: E12469.
52. Almholt K, Green KA, Juncker-Jensen A, Nielsen BS, Lund LR, Romer J. Extracellular proteolysis in transgenic mouse models of breast cancer. J Mammary Gland Biol Neoplasia 2007; 12: 83-97.
53. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174.
54. Walter P, Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science 2011; 334: 1081-1086.
55. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H et al. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/-mice reveals a role for translational control in secretory cell survival. Mol Cell 2001; 7: 1153-1163.
56. Liang G, Yang J, Wang Z, Li Q, Tang Y, Chen XZ. Polycystin-2 down-regulates cell proliferation via promoting PERK-dependent phosphorylation of eIF2alpha. Hum Mol Genet 2008; 17: 3254-3262.
57. Wei J, Sheng X, Feng D, McGrath B, Cavener DR. PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol 2008; 217: 693-707.
58. Merksamer PI, Papa FR. The UPR and cell fate at a glance. J Cell Sci 2010; 123: 1003-1006.
59. Gupta S, Read DE, Deepti A, Cawley K, Gupta A, Oommen D et al. Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis. Cell Death Dis 2012; 3: E333.
60. Liu CL, Li X, Hu GL, Li RJ, He YY, Zhong W et al. Salubrinal protects against tunicamycin and hypoxia induced cardiomyocyte apoptosis via the PERKeIF2alpha signaling pathway. J Geriatr Cardiol 2012; 9: 258-268.
61. Park MA, Zhang G, Martin AP, Hamed H, Mitchell C, Hylemon PB et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008; 7: 1648-1662.
62. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROSbased ER stress. Cell Death Differ 2012; 19: 1880-1891.
63. Talukder AH, Wang RA, Kumar R. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells. Oncogene 2002; 21: 4289-4300.
64. Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell 2007; 12: 221-234.
65. Espina V, Mariani BD, Gallagher RI, Tran K, Banks S, Wiedemann J et al. Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS One 2010; 5: E10240.
66. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009; 461: 109-113.
67. Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 2010; 29: 3881-3895.
68. Sequeira SJ, Wen HC, Avivar-Valderas A, Farias EF, Aguirre-Ghiso JA. Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis. BMC Cell Biol 2009; 10: 64.
69. Blais JD, Addison CL, Edge R, Falls T, Zhao H, Wary K et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 2006; 26: 9517-9532.
70. Avivar-Valderas A, Bobrovnikova-Marjon E, Alan Diehl J, Bardeesy N, Debnath J, Aguirre-Ghiso JA. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 2013; 32: 4932-4940.
71. Brewer JW, Diehl JA. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc Natl Acad Sci USA 2000; 97: 12625-12630.
72. Brewer JW, Hendershot LM, Sherr CJ, Diehl JA. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc Natl Acad Sci USA 1999; 96: 8505-8510.
73. Farmer SR, Ben-Ze'av A, Benecke BJ, Penman S. Altered translatability of messenger RNA from suspended anchorage-dependent fibroblasts: Reversal upon cell attachment to a surface. Cell 1978; 15: 627-637.
74. Benecke BJ, Ben-Ze'ev A, Penman S. The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts. Cell 1978; 14: 931-939.
75. Gorrini C, Loreni F, Gandin V, Sala LA, Sonenberg N, Marchisio PC et al. Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways. Proc Natl Acad Sci USA 2005; 102: 9200-9205.
76. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005; 24: 3470-3481.
77. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51-64.
78. Fung C, Lock R, Gao S, Salas E, Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell 2008; 19: 797-806.
79. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672-676.
80. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59: 59-65.
81. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 1062-1075.
82. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest 2012; 122: 4621-4634.
83. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 2009; 69: 4415-4423.
84. Park MA, Yacoub A, Sarkar D, Emdad L, Rahmani M, Spiegel S et al. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy 2008; 4: 513-515.
85. Debnath J. Detachment-induced autophagy during anoikis and lumen formation in epithelial acini. Autophagy 2008; 4: 351-353.
86. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435-2444.
87. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-811.
88. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420-7426.
89. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364: 229-233.
90. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997; 235: 533-538.
91. Sun P, Yoshizuka N, New L, Moser BA, Li Y, Liao R et al. PRAK is essential for ras-induced senescence and tumor suppression. Cell 2007; 128: 295-308.
92. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 2002; 31: 210-215.
93. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 2004; 36: 343-350.
94. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22: 3389-3403.
95. Mikhailov A, Patel D, McCance DJ, Rieder CL. The G2 p38-mediated stress-activated checkpoint pathway becomes attenuated in transformed cells. Curr Biol 2007; 17: 2162-2168.
96. Lambros MB, Natrajan R, Geyer FC, Lopez-Garcia MA, Dedes KJ, Savage K et al. PPM1D gene amplification and overexpression in breast cancer: A qRT-PCR and chromogenic in situ hybridization study. Mod Pathol 2010; 23: 1334-1345.
97. Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 2012; 493: 406-410.
98. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268.
99. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, Nagasaki K et al. Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol 2007; 27: 1730-1744.
100. Dong J, Huang S, Caikovski M, Ji S, McGrath A, Custorio MG et al. ID4 regulates mammary gland development by suppressing p38MAPK activity. Development 2011; 138: 5247-5256.
101. Akaogi K, Ono W, Hayashi Y, Kishimoto H, Yanagisawa J. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis. BMC Cancer 2013; 13: 65.
102. Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, Yu D. 14-3-3 zeta downregulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res 2008; 68: 1760-1767.
103. Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits cell detachmentinduced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 2005; 24: 1338-1347.
104. Yazinski SA, Westcott PM, Ong K, Pinkas J, Peters RM, Weiss RS. Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration. Proc Natl Acad Sci USA 2009; 106: 21282-21287.
105. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5: 897-904.
106. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ et al. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J 1995; 14: 5920-5930.
107. Bruno RD, Smith GH. Reprogramming non-mammary and cancer cells in the developing mouse mammary gland. Semin Cell Dev Biol 2012; 23: 591-598.
108. Kim MS, Lee EJ, Kim HR, Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003; 63: 5454-5461.
109. Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res 2010; 12: R107.
110. Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG et al. TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. Nat Cell Biol 2013; 15: 1351-1361.
111. O'Sullivan AW, Wang JH, Redmond HP. p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism. World J Surg Oncol 2009; 7: 89.
112. Timofeev O, Lee TY, Bulavin DV. A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis. Cell Cycle 2005; 4: 118-120.